Prescription opioid use in advanced COPD: benefits, perils and controversies

Eur Respir J. 2017 Jun 22;49(6):1700690. doi: 10.1183/13993003.00690-2017. Print 2017 Jun.

Authors

Natasha Smallwood¹, John Politis², Brian Le³

Affiliations

¹ Dept of Respiratory Medicine, The Royal Melbourne Hospital, Parkville, Australia Natasha.smallwood@mh.org.au.
² Dept of Respiratory Medicine, The Royal Melbourne Hospital, Parkville, Australia.
³ Palliative and Supportive Care, The Royal Melbourne Hospital, Parkville, Australia.

PMID: 28642317
DOI: 10.1183/13993003.00690-2017

No abstract available

Publication types

Letter
Comment

MeSH terms

Analgesics, Opioid*
Humans
Opioid-Related Disorders*
Pulmonary Disease, Chronic Obstructive

Substances

Analgesics, Opioid